These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20610144)

  • 1. Incidence, predictors and outcomes of subacute stent thrombosis following primary stenting for ST-elevation myocardial infarction.
    Chua SK; Hung HF; Cheng JJ; Wang JH; Lo HM; Kuan P; Lee SH; Lin SC; Liou JY; Chang CM; Chiu CZ; Shyu KC
    J Formos Med Assoc; 2010 Jun; 109(6):430-7. PubMed ID: 20610144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction.
    Smit JJ; van 't Hof AW; de Boer MJ; Hoorntje JC; Dambrink JH; Gosselink AT; Ottervanger JP; Kolkman JJ; Suryapranata H
    Thromb Haemost; 2006 Aug; 96(2):190-5. PubMed ID: 16894463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction.
    Brodie B; Pokharel Y; Garg A; Kissling G; Hansen C; Milks S; Cooper M; McAlhany C; Stuckey T
    JACC Cardiovasc Interv; 2012 Oct; 5(10):1043-51. PubMed ID: 23078734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
    Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
    Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome.
    Heestermans AA; van Werkum JW; Zwart B; van der Heyden JA; Kelder JC; Breet NJ; van't Hof AW; Dambrink JH; Koolen JJ; Brueren BR; Zijlstra F; ten Berg JM
    J Thromb Haemost; 2010 Nov; 8(11):2385-93. PubMed ID: 20831622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis.
    Ergelen M; Uyarel H; Osmonov D; Ayhan E; Akkaya E; Soylu O; Orhan AL; Sayar N; Bozbay M; Turer A; Yildirim E; Yekeler I
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):33-41. PubMed ID: 19736213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium as a predictor of acute stent thrombosis in patients with ST-segment elevation myocardial infarction who underwent primary angioplasty.
    Çiçek G; Açıkgoz SK; Yayla Ç; Kundi H; İleri M
    Coron Artery Dis; 2016 Jan; 27(1):47-51. PubMed ID: 26513291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of direct stenting on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry).
    Dziewierz A; Siudak Z; Rakowski T; Kleczyński P; Zasada W; Dubiel JS; Dudek D
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):925-31. PubMed ID: 24155092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
    De Luca G; Dirksen MT; Spaulding C; Kelbaek H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Díaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Cortese G; Suryapranata H; Stone GW;
    Arch Intern Med; 2012 Apr; 172(8):611-21; discussion 621-2. PubMed ID: 22529227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome.
    Moussa I; Di Mario C; Reimers B; Akiyama T; Tobis J; Colombo A
    J Am Coll Cardiol; 1997 Jan; 29(1):6-12. PubMed ID: 8996288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome.
    Beinart R; Abu Sham'a R; Segev A; Hod H; Guetta V; Shechter M; Boyko V; Behar S; Matetzky S
    Am Heart J; 2010 Jan; 159(1):118-24. PubMed ID: 20102877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction.
    Heestermans AA; Van Werkum JW; Hamm C; Dill T; Gosselink AT; De Boer MJ; Van Houwelingen G; Hoorntje JC; Koopmans PC; Ten Berg JM; Van 't Hof AW
    J Thromb Haemost; 2009 Oct; 7(10):1612-8. PubMed ID: 19682233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial.
    Fiocca L; Guagliumi G; Rossini R; Parise H; Musumeci G; Sirbu V; Lortkipanidze N; Yu J; Mihalcsik L; Vassileva A; Valsecchi O; Gavazzi A; Mehran R; Stone GW
    Am J Cardiol; 2013 Jan; 111(2):196-201. PubMed ID: 23111141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors.
    De Luca G; Gibson CM; Bellandi F; Noc M; Dudek D; Zeymer U; Arntz HR; Cutlip D; Maioli M; Zorman S; Mesquita Gabriel H; Emre A; Rakowski T; Gyongyosi M; Huber K; Van't Hof AW
    Atherosclerosis; 2009 Nov; 207(1):181-5. PubMed ID: 19426981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
    Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.